MX2022011431A - Compuesto de oxazolidinona y metodos de uso de este como agente antibacteriano. - Google Patents
Compuesto de oxazolidinona y metodos de uso de este como agente antibacteriano.Info
- Publication number
- MX2022011431A MX2022011431A MX2022011431A MX2022011431A MX2022011431A MX 2022011431 A MX2022011431 A MX 2022011431A MX 2022011431 A MX2022011431 A MX 2022011431A MX 2022011431 A MX2022011431 A MX 2022011431A MX 2022011431 A MX2022011431 A MX 2022011431A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- formula
- methods
- antibacterial agent
- oxazolidinone compound
- Prior art date
Links
- -1 Oxazolidinone compound Chemical class 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010062207 Mycobacterial infection Diseases 0.000 abstract 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere al compuesto de oxazolidinona de la Fórmula I: (ver Fórmula) (I) y sales farmacéuticamente aceptables del mismo. La presente invención también se refiere a composiciones que contienen el compuesto de la Fórmula I. La invención también proporciona métodos para inhibir el crecimiento de células micobacterianas así como un método para tratar infecciones por micobacterias por Mycobacterium tuberculosis al administrar una cantidad terapéuticamente eficaz de la Fórmula I y/o una sal farmacéuticamente aceptable del mismo, o una composición que comprende tal compuesto y/o sal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2020/080359 WO2021184339A1 (en) | 2020-03-20 | 2020-03-20 | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
| PCT/US2021/022652 WO2021188606A1 (en) | 2020-03-20 | 2021-03-17 | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022011431A true MX2022011431A (es) | 2022-10-03 |
Family
ID=75478174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022011431A MX2022011431A (es) | 2020-03-20 | 2021-03-17 | Compuesto de oxazolidinona y metodos de uso de este como agente antibacteriano. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP4121058A1 (es) |
| JP (1) | JP7241984B2 (es) |
| KR (1) | KR20220156577A (es) |
| CN (1) | CN115605208A (es) |
| AR (1) | AR121598A1 (es) |
| AU (1) | AU2021239937B2 (es) |
| BR (1) | BR112022018674A2 (es) |
| CA (1) | CA3172304A1 (es) |
| CL (1) | CL2022002511A1 (es) |
| CO (1) | CO2022013595A2 (es) |
| CR (1) | CR20220472A (es) |
| EC (1) | ECSP22073580A (es) |
| IL (1) | IL296401A (es) |
| MX (1) | MX2022011431A (es) |
| PE (1) | PE20230002A1 (es) |
| TW (1) | TWI799814B (es) |
| WO (2) | WO2021184339A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022016063A (es) | 2020-06-18 | 2023-04-11 | Akagera Medicines Inc | Compuestos de oxazolidinona, composiciones de liposomas que comprenden compuestos de oxazolidinona y metodos de uso de los mismos. |
| WO2023102363A1 (en) * | 2021-11-30 | 2023-06-08 | Mannkind Corporation | Formulation and method for topical treatment of mycobacterium ulcerans in buruli ulcers |
| EP4296674A1 (en) | 2022-06-20 | 2023-12-27 | Université Toulouse III - Paul Sabatier | Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis |
| WO2024035618A1 (en) * | 2022-08-10 | 2024-02-15 | Merck Sharp & Dohme Llc | Processes for preparing oxazolidinone compounds |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| SK7572002A3 (en) * | 1999-12-21 | 2002-12-03 | Upjohn Co | Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| PE20020044A1 (es) * | 2000-06-16 | 2002-01-30 | Upjohn Co | Tiazina oxazolidinona |
| AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| MXPA03003473A (es) * | 2000-10-17 | 2003-08-19 | Upjohn Co | Metodos para producir compuestos de oxazolidinona. |
| MXPA03006958A (es) * | 2001-02-05 | 2003-11-18 | Upjohn Co | Composicion para administracion rectal de farmaco antibacterial de oxazolidinona. |
| GB0108764D0 (en) * | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
| AR038576A1 (es) * | 2002-02-22 | 2005-01-19 | Pharmacia Corp | Formulaciones de drogas antibioticas oftalmicas que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio |
| WO2005113520A1 (en) * | 2004-05-20 | 2005-12-01 | Pharmacia & Upjohn Company Llc | Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents |
| JP2008508271A (ja) | 2004-07-28 | 2008-03-21 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | ビアリール複素環式化合物ならびにその化合物を製造および使用する方法 |
| WO2006059221A2 (en) * | 2004-12-03 | 2006-06-08 | Pharmacia & Upjohn Company Llc | Topical hydro-alcoholic formulations of oxazolidinone antibacterial agents |
| WO2006079896A2 (en) * | 2005-01-27 | 2006-08-03 | Pharmacia & Upjohn Company Llc | Stable polyol formulations of oxazolidinone antibacterial agents |
| CN102131811A (zh) | 2008-06-24 | 2011-07-20 | 财团法人乙卯研究所 | 具有稠合环的*唑烷酮衍生物 |
| US20110190199A1 (en) * | 2008-09-03 | 2011-08-04 | Pfizer Inc. | Combination Therapy for Tuberculosis |
| EP2311457A1 (en) * | 2009-10-19 | 2011-04-20 | Forschungszentrum Borstel | Pharmaceutical compositions for treating infections with drug resistant mycobacteria |
| EP3307268B1 (en) * | 2015-07-17 | 2021-09-01 | The Global Alliance for TB Drug Development, Inc. | Substituted phenyloxazolidinones for antimicrobial therapy |
| WO2017066964A1 (en) * | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| WO2018170664A1 (en) * | 2017-03-20 | 2018-09-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
-
2020
- 2020-03-20 WO PCT/CN2020/080359 patent/WO2021184339A1/en active Application Filing
-
2021
- 2021-03-17 IL IL296401A patent/IL296401A/en unknown
- 2021-03-17 CR CR20220472A patent/CR20220472A/es unknown
- 2021-03-17 BR BR112022018674A patent/BR112022018674A2/pt not_active Application Discontinuation
- 2021-03-17 TW TW110109522A patent/TWI799814B/zh active
- 2021-03-17 JP JP2022555750A patent/JP7241984B2/ja active Active
- 2021-03-17 MX MX2022011431A patent/MX2022011431A/es unknown
- 2021-03-17 KR KR1020227035951A patent/KR20220156577A/ko active Search and Examination
- 2021-03-17 AU AU2021239937A patent/AU2021239937B2/en active Active
- 2021-03-17 PE PE2022002043A patent/PE20230002A1/es unknown
- 2021-03-17 WO PCT/US2021/022652 patent/WO2021188606A1/en active Application Filing
- 2021-03-17 EP EP21718283.1A patent/EP4121058A1/en active Pending
- 2021-03-17 AR ARP210100669A patent/AR121598A1/es unknown
- 2021-03-17 CA CA3172304A patent/CA3172304A1/en active Pending
- 2021-03-17 CN CN202180036146.XA patent/CN115605208A/zh active Pending
-
2022
- 2022-09-14 CL CL2022002511A patent/CL2022002511A1/es unknown
- 2022-09-19 EC ECSENADI202273580A patent/ECSP22073580A/es unknown
- 2022-09-21 CO CONC2022/0013595A patent/CO2022013595A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR121598A1 (es) | 2022-06-22 |
| WO2021184339A1 (en) | 2021-09-23 |
| CR20220472A (es) | 2022-11-14 |
| CA3172304A1 (en) | 2021-09-23 |
| EP4121058A1 (en) | 2023-01-25 |
| IL296401A (en) | 2022-11-01 |
| WO2021188606A1 (en) | 2021-09-23 |
| BR112022018674A2 (pt) | 2022-11-01 |
| KR20220156577A (ko) | 2022-11-25 |
| AU2021239937B2 (en) | 2023-10-26 |
| TW202200573A (zh) | 2022-01-01 |
| CL2022002511A1 (es) | 2023-03-24 |
| JP7241984B2 (ja) | 2023-03-17 |
| AU2021239937A1 (en) | 2022-10-06 |
| ECSP22073580A (es) | 2022-11-30 |
| PE20230002A1 (es) | 2023-01-05 |
| TWI799814B (zh) | 2023-04-21 |
| JP2023507683A (ja) | 2023-02-24 |
| CO2022013595A2 (es) | 2023-02-16 |
| CN115605208A (zh) | 2023-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022011431A (es) | Compuesto de oxazolidinona y metodos de uso de este como agente antibacteriano. | |
| EA200970535A1 (ru) | Антибактериальные производные хинолина | |
| MXPA05001052A (es) | Derivados de quinolina y su uso como inhibidores micobacterianos. | |
| EA202090604A1 (ru) | Хроманмонобактамовые соединения для лечения бактериальных инфекций | |
| MX2020011317A (es) | Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih. | |
| MX2009013581A (es) | Derivados de 4-(n-azacicloalquil)anilidas como moduladores del canal de potasio. | |
| NO20081008L (no) | Antibakterielle kinolinderivater | |
| EA200970534A1 (ru) | Антибактериальные производные хинолина | |
| JOP20210353A1 (ar) | مركبات وطرق استخدامها كعوامل مضادة للجراثيم | |
| JO2725B1 (en) | Quinoline antibacterial derivatives | |
| PH12020551117A1 (en) | Compositions for preventing or treating uveitis | |
| EA200970536A1 (ru) | Антибактериальные хинолиновые производные | |
| JO3270B1 (ar) | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا | |
| MX2023009445A (es) | Compuestos de heterociclos tetraciclicos utiles como inhibidores de la integrasa del vih. | |
| MX2022011240A (es) | Azálidos de urea inmunomoduladores. | |
| WO2020096916A3 (en) | Inhibitors of histone deacetylase useful for the treatment or prevention of hiv infection | |
| EA200970537A1 (ru) | Антибактериальные производные хинолина | |
| WO2023150291A3 (en) | Heterocyclic compounds and methods of use | |
| MX2023010797A (es) | Profarmacos antivirales de entecavir (etv) y formulaciones de los mismos. | |
| MX2023010821A (es) | Compuestos ciclicos y metodos de uso. | |
| WO2023245015A3 (en) | Phenyl amide compounds and methods of use |